{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:09:15Z","timestamp":1772842155768,"version":"3.50.1"},"reference-count":47,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3,1]]},"abstract":"<jats:p>Headache is a frequent symptom in sickle cell disease (SCD) that usually is attributable to anemia or cerebrovascular disease. We report 3 pediatric patients with SCD (1 patient with SCD-SC and 2 patients with SCD-SS) who presented with headache and were diagnosed with pseudotumor cerebri (PC). All 3 patients had elevated opening pressures during a lumbar puncture with normal cerebrospinal fluid studies. Magnetic resonance imaging revealed no evidence of hydrocephalus or arteriopathy in all 3 cases. Magnetic resonance venograms performed in 2 of the patients at diagnosis revealed no evidence of cerebral sinus thrombosis. Each patient received a thorough ophthalmologic examination. A diagnostic funduscopic examination revealed bilateral papilledema without signs of retinopathy in all 3 patients. There were no clinically significant changes in visual acuity or abnormalities of color vision in any patient. Goldmann or Humphrey visual-field assessment was abnormal only in patient 1, who demonstrated bilaterally enlarged blind spots at diagnosis and later developed reduced sensitivity in the inferomedial quadrant of the left eye in an arcuate pattern (which later resolved). The diagnosis of PC was made in all 3 patients, and acetazolamide treatment was started. Two of the patients\u2019 symptoms resolved completely with medical treatment, whereas the third patient\u2019s symptoms improved. None of these patients had permanent visual-field deficits as a result of their syndrome. PC has been reported in several other types of anemia including SCD-SC, but these cases are the first reported in conjunction with pediatric SCD. Early recognition of the signs and symptoms of PC in patients with SCD who present with headache can expedite proper diagnosis and treatment and prevent long-term ophthalmologic sequelae.<\/jats:p>","DOI":"10.1542\/peds.113.3.e265","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"e265-e269","source":"Crossref","is-referenced-by-count":41,"title":["Pseudotumor Cerebri in Children With Sickle Cell Disease: A Case Series"],"prefix":"10.1542","volume":"113","author":[{"given":"Michael","family":"Henry","sequence":"first","affiliation":[{"name":"Departments of Hematology\/Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Catherine","family":"Driscoll","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijean","family":"Miller","sequence":"additional","affiliation":[{"name":"Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeun","family":"Chang","sequence":"additional","affiliation":[{"name":"Neurology, Children\u2019s National Medical Center, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina P.","family":"Minniti","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2004,3,1]]},"reference":[{"key":"2021121006112002000_R1","doi-asserted-by":"crossref","unstructured":"Fixler J, Styles L. Sickle cell disease. Pediatr Clin North Am.2002;49:1193\u20131210","DOI":"10.1016\/S0031-3955(02)00089-5"},{"key":"2021121006112002000_R2","doi-asserted-by":"crossref","unstructured":"Adams RJ, Ohene-Frempong K, Wang W. Sickle cell and the brain. Hematology (Am Soc Hematol Educ Program).2001:31\u201346","DOI":"10.1182\/asheducation-2001.1.31"},{"key":"2021121006112002000_R3","doi-asserted-by":"crossref","unstructured":"Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics.1999;103:640\u2013645","DOI":"10.1542\/peds.103.3.640"},{"key":"2021121006112002000_R4","doi-asserted-by":"crossref","unstructured":"Prengler M, Pavlakis SG, Prohovnik I, et al. Sickle cell disease: the neurological complications. Ann Neurol.2002;51:543\u2013552","DOI":"10.1002\/ana.10192"},{"key":"2021121006112002000_R5","doi-asserted-by":"crossref","unstructured":"Adams R, McKie V, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials.1998;19:110\u2013129","DOI":"10.1016\/S0197-2456(97)00099-8"},{"key":"2021121006112002000_R6","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood.1998;91:288\u2013294"},{"key":"2021121006112002000_R7","unstructured":"Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol.1996;17:965\u2013972"},{"key":"2021121006112002000_R8","doi-asserted-by":"crossref","unstructured":"Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood.2002;99:3014\u20133018","DOI":"10.1182\/blood.V99.8.3014"},{"key":"2021121006112002000_R9","doi-asserted-by":"crossref","unstructured":"Wang W, Enos L, Gallagher D, et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr.2001;139:391\u2013397","DOI":"10.1067\/mpd.2001.116935"},{"key":"2021121006112002000_R10","unstructured":"Goldberg MF. Retinal vaso-occlusion in sickling hemoglobinopathies. Birth Defects Orig Artic Ser.1976;12:475\u2013515"},{"key":"2021121006112002000_R11","unstructured":"Lutty G, Goldberg M. Ophthalmologic complications. In: Embury S, Hebbel R, Mohandas N, Steinberg M, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press, Ltd; 1994:703\u2013723"},{"key":"2021121006112002000_R12","doi-asserted-by":"crossref","unstructured":"Fine LC, Petrovic V, Irvine AR, et al. Spontaneous central retinal artery occlusion in hemoglobin sickle cell disease. Am J Ophthalmol.2000;129:680\u2013681","DOI":"10.1016\/S0002-9394(00)00361-5"},{"key":"2021121006112002000_R13","doi-asserted-by":"crossref","unstructured":"Mansi IA, Alkhunaizi AM, Al-Khatti AA. Bilateral central retinal artery occlusion secondary to sickle cell disease. Am J Hematol.2000;64:79\u201380","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<79::AID-AJH18>3.0.CO;2-C"},{"key":"2021121006112002000_R14","doi-asserted-by":"crossref","unstructured":"Wall M. Idiopathic intracranial hypertension. Neurol Clin.1991;9:73\u201395","DOI":"10.1016\/S0733-8619(18)30304-9"},{"key":"2021121006112002000_R15","doi-asserted-by":"crossref","unstructured":"Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol.1999;127:178\u2013182","DOI":"10.1016\/S0002-9394(98)00386-9"},{"key":"2021121006112002000_R16","doi-asserted-by":"crossref","unstructured":"Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol.1994;9:144\u2013149","DOI":"10.1177\/088307389400900208"},{"key":"2021121006112002000_R17","doi-asserted-by":"crossref","unstructured":"Uddin AB. Drug-induced pseudotumor cerebri. Clin Neuropharmacol.2003;26:236\u2013238","DOI":"10.1097\/00002826-200309000-00007"},{"key":"2021121006112002000_R18","doi-asserted-by":"crossref","unstructured":"Henry SD, Jacques S. Benign intracranial hypertension in pregnancy. JACEP.1979;8:323\u2013325","DOI":"10.1016\/S0361-1124(79)80374-3"},{"key":"2021121006112002000_R19","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Iyengar S, Goldenberg N, et al. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med.2003;142:35\u201345","DOI":"10.1016\/S0022-2143(03)00069-6"},{"key":"2021121006112002000_R20","unstructured":"Li EK, Ho PC. Pseudotumor cerebri in systemic lupus erythematosus. J Rheumatol.1989;16:113\u2013116"},{"key":"2021121006112002000_R21","unstructured":"Hannerz J, Greitz D, Ericson K. Is there a relationship between obesity and intracranial hypertension?Int J Obes Relat Metab Disord.1995;19:240\u2013244"},{"key":"2021121006112002000_R22","unstructured":"Sheldon RS, Becker WJ, Hanley DA, et al. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association. Can J Neurol Sci.1987;14:622\u2013625"},{"key":"2021121006112002000_R23","doi-asserted-by":"crossref","unstructured":"Tamer SK, Tamer U, Warey P. Infantile pseudotumor cerebri related to viral illness. Indian J Pediatr.1996;63:645\u2013649","DOI":"10.1007\/BF02730810"},{"key":"2021121006112002000_R24","doi-asserted-by":"crossref","unstructured":"Thron A, Wessel K, Linden D, et al. Superior sagittal sinus thrombosis: neuroradiological evaluation and clinical findings. J Neurol.1986;233:283\u2013288","DOI":"10.1007\/BF00314160"},{"key":"2021121006112002000_R25","doi-asserted-by":"crossref","unstructured":"Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol.1992;37:155\u2013166","DOI":"10.1016\/0039-6257(92)90134-F"},{"key":"2021121006112002000_R26","doi-asserted-by":"crossref","unstructured":"Jeng MR, Rieman M, Bhakta M, et al. Pseudotumor cerebri in two adolescents with acquired aplastic anemia. J Pediatr Hematol Oncol.2002;24:765\u2013768","DOI":"10.1097\/00043426-200212000-00018"},{"key":"2021121006112002000_R27","doi-asserted-by":"crossref","unstructured":"Tugal O, Jacobson R, Berezin S, et al. Recurrent benign intracranial hypertension due to iron deficiency anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol.1994;16:266\u2013270","DOI":"10.1097\/00043426-199408000-00015"},{"key":"2021121006112002000_R28","doi-asserted-by":"crossref","unstructured":"Yager JY, Hartfield DS. Neurologic manifestations of iron deficiency in childhood. Pediatr Neurol.2002;27:85\u201392","DOI":"10.1016\/S0887-8994(02)00417-4"},{"key":"2021121006112002000_R29","unstructured":"Benoit P, Lozes G, Destee A, et al. Benign intracranial hypertension and Marchiafava-Micheli disease [in French]. Rev Neurol (Paris).1986;142:782\u2013785"},{"key":"2021121006112002000_R30","doi-asserted-by":"crossref","unstructured":"van Gelder T, van Gemert H, Tjiong H. A patient with megaloblastic anaemia and idiopathic intracranial hypertension. Case history. Clin Neurol Neurosurg.1991;93:321\u2013322","DOI":"10.1016\/0303-8467(91)90098-A"},{"key":"2021121006112002000_R31","doi-asserted-by":"crossref","unstructured":"Murphy T, JJ C. Pseudotumor cerebri associated with pernicious anemia. Ann Intern Med.1969;70:777\u2013782","DOI":"10.7326\/0003-4819-70-4-777"},{"key":"2021121006112002000_R32","doi-asserted-by":"crossref","unstructured":"Thomas E. Recurrent benign intracranial hypertension associated with hemoglobin SC disease in pregnancy. Obstet Gynecol.1986;67(3 suppl):7S\u20139S","DOI":"10.1097\/00006250-198603001-00002"},{"key":"2021121006112002000_R33","doi-asserted-by":"crossref","unstructured":"Rowe FJ, Sarkies NJ. The relationship between obesity and idiopathic intracranial hypertension. Int J Obes Relat Metab Disord.1999;23:54\u201359","DOI":"10.1038\/sj.ijo.0800758"},{"key":"2021121006112002000_R34","doi-asserted-by":"crossref","unstructured":"Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol.2002;17:745\u2013748","DOI":"10.1177\/08830738020170101401"},{"key":"2021121006112002000_R35","doi-asserted-by":"crossref","unstructured":"Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology.1999;52:870\u2013872","DOI":"10.1212\/WNL.52.4.870"},{"key":"2021121006112002000_R36","doi-asserted-by":"crossref","unstructured":"Serjeant GR. Sickle-cell disease. Lancet.1997;350:725\u2013730","DOI":"10.1016\/S0140-6736(97)07330-3"},{"key":"2021121006112002000_R37","doi-asserted-by":"crossref","unstructured":"Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA.2003;289:1645\u20131651","DOI":"10.1001\/jama.289.13.1645"},{"key":"2021121006112002000_R38","doi-asserted-by":"crossref","unstructured":"Borba R, Lima CS, Grotto HZ. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy. J Clin Lab Anal.2003;17:66\u201372","DOI":"10.1002\/jcla.10070"},{"key":"2021121006112002000_R39","doi-asserted-by":"crossref","unstructured":"Ballas SK, Lewis CN, Noone AM, et al. Clinical, hematological, and biochemical features of Hb SC disease. Am J Hematol.1982;13:37\u201351","DOI":"10.1002\/ajh.2830130106"},{"key":"2021121006112002000_R40","doi-asserted-by":"crossref","unstructured":"Nath KA, Shah V, Haggard JJ, et al. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol.2000;279:R1949\u2013R1955","DOI":"10.1152\/ajpregu.2000.279.6.R1949"},{"key":"2021121006112002000_R41","unstructured":"Siegel G, Agranoff B, Albers R, et al, eds. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Sixth ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 1998"},{"key":"2021121006112002000_R42","doi-asserted-by":"crossref","unstructured":"Rubin RC, Henderson ES, Ommaya AK, et al. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg.1966;25:430\u2013436","DOI":"10.3171\/jns.1966.25.4.0430"},{"key":"2021121006112002000_R43","doi-asserted-by":"crossref","unstructured":"Rassam SM, Patel V, Kohner EM. The effect of acetazolamide on the retinal circulation. Eye.1993;7:697\u2013702","DOI":"10.1038\/eye.1993.159"},{"key":"2021121006112002000_R44","unstructured":"Lenfant C. The Management of Sickle Cell Disease. Report no. 02-2117. Bethesda, MD: National Institutes of Health\/National Heart, Lung, and Blood Institute; 2002"},{"key":"2021121006112002000_R45","doi-asserted-by":"crossref","unstructured":"Brugnara C. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease. Curr Opin Hematol.1995;2:132\u2013138","DOI":"10.1097\/00062752-199502020-00005"},{"key":"2021121006112002000_R46","doi-asserted-by":"crossref","unstructured":"Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol.1982;39:461\u2013474","DOI":"10.1001\/archneur.1982.00510200003001"},{"key":"2021121006112002000_R47","doi-asserted-by":"crossref","unstructured":"Kirkham FJ, Calamante F, Bynevelt M, et al. Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol.2001;49:477\u2013485","DOI":"10.1002\/ana.97"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/3\/e265\/1014922\/zpe0030400e265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/3\/e265\/1014922\/zpe0030400e265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:58:28Z","timestamp":1639144708000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/113\/3\/e265\/63875\/Pseudotumor-Cerebri-in-Children-With-Sickle-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,1]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,3,1]]},"published-print":{"date-parts":[[2004,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.113.3.e265","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,1]]}}}